Health Canada releases first drug review, on Diane-35

Tagged :
Print
Taille du texte: Normal / Moyen / Grand
Version imprimableVersion imprimable

Health Canada’s recent short summary of Diane 35 raises more questions than it answers, according to an article in the Toronto Star. Drug safety researcher Barbara Mintzes called the assessment “highly problematic” and “quite limited” in scope.

Diane-35 has been linked to several deaths of young women in Canada. About 40,000 Canadian women are on the pill, which is approved for what is considered otherwise untreatable acne, Health Canada has reported.

Read Health Canada releases summary report of controversial drug Diane-35

See more about Health Canada’s Diane-35 drug review in the Globe and Mail: Review of acne drug related to deaths first of reviews to be released on new website.

Explore more on CWHN about this issue, in Diane-35: Reconsidering the risks by Holly Grigg-Spall.